Specifically, gliomas are divided into IDH-mutant (IDHmt) and IDH-wild type (IDHwt), IDHmt further subdivided to the ones bearing 1p/19q codeletion and ones with the ATRX (ATP-dependent helicase ATRX, X-linked helicase II) mutation. Here, IDH1 is linked to central nervous system cancer.